Clinical Trial Update: Satraplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated the combination of satraplatin with paclitaxel in patients with advanced non-small cell lung cancer; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• PACLITAXEL (PACLITAXEL)
• satraplatin (satraplatin)

Snippet

Sponsor: Agennix | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED